Featured Article

Ken Getz of Tufts CSDD and Steve Young of CluePoints Discuss Stand Out Results from Recent RBQM Study

In part 2 of this video interview series, Ken Getz, executive director and research professor, Tufts Center for the Study of Drug Development, Tufts University School of Medicine and Steve Young, chief science officer, CluePoints highlight what stood out to them from the results of a recent study on RBQM adoption.

Guide

A Comprehensive Guide to Adaptive Site Monitoring

Press Release
CluePoints Proven AI Innovation Earns Dual Recognition at SCDM and SCRIP Awards
Press Release
CluePoints Sponsored RBQMLive Returns for 2025
Blog
What to Expect at RBQMLive 2025: A Glimpse Into the Industry’s Leading RBQM Event
That’s a Wrap!
All three sessions are available on demand and ready to watch, revisit, save, or share.